Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and other payables

v3.10.0.1
Accrued Expenses and other payables
9 Months Ended
Sep. 30, 2018
Accrued Liabilities, Current [Abstract]  
Accrued Expenses and other payables

7. Accrued Expenses and other payables


Accrued expenses and other payables consist of the following:


 

 

September 30,
2018

 

December 31,
2017

 

 

 

 

 

 

 

 

 

Accrued clinical trial and other expenses

 

$

1,314,133

 

$

1,504,240

 

Compensation and related benefits

 

 

86,038

 

 

542,434

 

Deferred rent

 

 

13,349

 

 

27,457

 

Patent fees

 

 

35,000

 

 

40,000

 

Other expenses

 

 

82,300

 

 

162,300

 

 

 

$

1,530,820

 

$

2,276,431